Search results for "Drug Utilization"

showing 10 items of 34 documents

Managing adult patients with infectious diseases in emergency departments: international ID-IRI study.

2021

We aimed to explore factors for optimizing antimicrobial treatment in emergency departments. A single-day point prevalence survey was conducted on January 18, 2020, in 53 referral/tertiary hospitals in 22 countries. 1957 (17%) of 11557 patients presenting to EDs had infections. The mean qSOFA score was 0.37 +/- 0.74. Sepsis (qSOFA >= 2) was recorded in 218 (11.1%) patients. The mean qSOFA score was significantly higher in low-middle (1.48 +/- 0.963) compared to upper-middle (0.17 +/- 0.482) and high-income (0.36 +/- 0.714) countries ( P < 0.001). Eight (3.7%) patients with sepsis were treated as outpatients. The most common diagnoses were upper-respiratory (n = 877, 43.3%), lower-respirator…

0301 basic medicinePoint prevalence surveymedicine.medical_specialtyUrologic NeoplasmsReferralinternational ID-IRI study- JOURNAL OF CHEMOTHERAPY 2021 [Erdem H. Hargreaves S. ANKARALI H. ÇAŞKURLU H. Ceviker S. A. Bahar-Kacmaz A. Meric-Koc M. ALTINDİŞ M. Yildiz-Kirazaldi Y. Kizilates F. et al. -Managing adult patients with infectious diseases in emergency departments]medicine.drug_classOrgan Dysfunction Scores030106 microbiologyAntibioticsPractice Patternsemergency ; antibiotic ; elderly ; infection ; sepsis ; treatmentGlobal HealthelderlyCommunicable Diseasestreatment.SepsisHospital03 medical and health sciences0302 clinical medicineantibioticSepsismedicineHumansPharmacology (medical)Practice Patterns Physicians'Developing CountriesRespiratory Tract InfectionsPharmacologyEmergency ServicePhysicians'Adult patientstreatmentbusiness.industryPatient AcuityAntimicrobialmedicine.diseasehumanitiesinfectionDrug UtilizationAnti-Bacterial AgentsInfectious DiseasesOncology030220 oncology & carcinogenesisEmergency medicineEmergencysepsibusinessEmergency Service HospitalJournal of chemotherapy (Florence, Italy)
researchProduct

Use of illicit and prescription drugs for cognitive or mood enhancement among surgeons.

2012

Background Surgeons are usually exposed to high workloads leading to fatigue and stress. This not only increases the likelihood of mistakes during surgery but also puts pressure on surgeons to use drugs to counteract fatigue, distress, concentration deficits, burnout or symptoms of depression. The prevalence of surgeons taking pharmacological cognitive enhancement (CE) or mood enhancement (ME) drugs has not been systematically assessed so far. Methods Surgeons who attended five international conferences in 2011 were surveyed with an anonymous self-report questionnaire (AQ) regarding the use of prescription or illicit drugs for CE and ME and factors associated with their use. The Randomized …

AdultAged 80 and overMalePsychotropic DrugsPrescription DrugsIllicit DrugsMiddle AgedDrug UtilizationYoung AdultPhysiciansSurveys and QuestionnairesHumansSurgeon(s)FemalePrescription drug(s)Nootropic AgentsStimulant(s)AgedResearch ArticleCognitive enhancementBMC medicine
researchProduct

The use of proton pump inhibitors in an Italian hospital: focus on oncologic and critical non-ICU patients

2015

Background Proton pump inhibitors (PPIs) are among the most misused drugs both at the community and hospital level. Recently, possible risks have been underscored, suggesting the importance of limiting PPI use to proven indications. Objective To survey the appropriateness of PPI use in a University hospital in Italy. Setting Azienda Ospedaliera Universitaria Policlinico ‘P. Giaccone’, in Palermo, Italy. Method A one day-observational study, reviewing patients’ medical records to identify treatments with PPIs and the indications for their use. After discharge, a subgroup of the cohort was followed up to assess the continuation of therapy at home. Appropriateness was evaluated according to th…

AdultMaleDrug UtilizationDrugmedicine.medical_specialtyIcu patientsmedia_common.quotation_subjectPharmaceutical ScienceInappropriate PrescribingPharmacyPharmacyProton pump inhibitorToxicologyHospitals UniversityHospitalmedicineDrug utilizationHumansPharmacology (medical)Stomach UlcerMedical prescriptionIntensive care medicineAgedmedia_commonPharmacologybusiness.industryMedical recordStress ulcerProton Pump InhibitorsMiddle Agedmedicine.diseasePatient DischargeHospitalizationTherapeutic appropriateneItalyPractice Guidelines as TopicCohortSettore BIO/14 - FarmacologiaFemaleGuideline Adherencebusiness
researchProduct

Are medical residents a "core group" for for future improvement of influenza vaccination coverage in health-care workers? A study among medical resid…

2011

Abstract Despite international recommendations, vaccination coverage among European healthcare workers, including physicians, is widely recognized as unsatisfactory. In order to plan tailored vaccination campaigns and increase future coverage, we investigated reasons for refusing vaccination and determinants associated with influenza vaccine uptake among young health care workers. A survey was carried out during September and October 2010 on medical residents attending post-graduate Schools of the Medical Faculty at the University of Palermo (Italy). Each participant completed an anonymous web-based questionnaire including items on demographic and occupational characteristics, knowledge, at…

AdultMaleHealth Knowledge Attitudes PracticeInfluenza vaccineAttitude of Health PersonnelInfluenza vaccination acceptance healthcare workers medical residentsSettore MED/42 - Igiene Generale E ApplicataHospitals UniversityProfessional CompetenceEnvironmental healthSurveys and QuestionnairesHealth carePandemicInfluenza HumanMedical Staff HospitalMedicineHumansSicilyGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryVaccinationPublic Health Environmental and Occupational Healthvirus diseasesUniversity hospitalDrug UtilizationVaccinationInfectious DiseasesVaccination CampaignsInfluenza VaccinesVaccination coverageImmunologyHuman mortality from H5N1Molecular MedicineFemalebusiness
researchProduct

Influence of state anxiety and trate anxiety in postoperative in oral surgery

2014

Introduction: The aim of this article was to study the influence of anxiety (both state and trait) in postoperative recovery after extraction of third molar together, to establish the role of each of the aspects of anxiety in the results you obtained in an independent and complementary way. Material and Methods: We performed a prospective study of a consecutive series of 88 patients who underwent lower third molar extractions. Before being provided with any information about the operation, patients were asked to complete the Spielberger State-Trait Anxiety Inventory-Trait and State. We have evaluated postoperative swelling and pain, patients completed a 10-point visual analog scale (VAS) at…

AdultMaleMolarVisual analogue scaleOral surgeryPostoperative painAnalgesicSatisfactionSpielberger state-trait anxiety inventoryOdontologíaPostoperative recoveryAnxietyPostoperative ComplicationsmedicineEdemaHumansProspective StudiesProspective cohort studyGeneral DentistryAnalgesicsPain Postoperativebusiness.industryResearchThird molar surgery:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludDrug UtilizationOtorhinolaryngologyAnesthesiaUNESCO::CIENCIAS MÉDICASTooth ExtractionAnxietyFemaleMolar ThirdSurgeryOral Surgerymedicine.symptombusiness
researchProduct

Prescription patterns and appropriateness of NSAID therapy according to gastrointestinal risk and cardiovascular history in patients with diagnoses o…

2011

Abstract Background Prescription of non-steroidal anti-inflammatory drugs (NSAIDs) should be based on the assessment of both gastrointestinal (GI) and cardiovascular (CV) risk for the individual patient. We aimed to assess the GI/CV risk profile and the pharmacological management of patients with osteoarthritis (OA) in clinical practice. Methods We conducted a cross-sectional, multicentre, observational study of consecutive OA patients that visited 1,760 doctors throughout the Spanish National Health System (NHS) in a single day. The presence of GI risk factors, CV histories, hypertension and current pharmacological treatments was recorded. Results Of the 60,868 patients, 17,105 had a diagn…

AdultMalemedicine.medical_specialtymedicine.drug_classGastrointestinal DiseasesPopulationProton-pump inhibitorlcsh:MedicineOsteoarthritisRisk AssessmentInternal medicineOsteoarthritisMedicineHumansProspective StudiesRisk factorMedical diagnosisMedical prescriptioneducationAgedAged 80 and overMedicine(all)education.field_of_studyCardiovascular Historybusiness.industrylcsh:RAnti-Inflammatory Agents Non-SteroidalGeneral MedicineMiddle Agedmedicine.diseaseDrug UtilizationCross-Sectional StudiesPrescriptionsCardiovascular DiseasesSpainPhysical therapyObservational studyFemaleGuideline AdherencebusinessResearch ArticleBMC Medicine
researchProduct

Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir i…

2013

Objectives: To explore the durability of three first-line tenofovir/emtricitabine-based regimens in combination with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in HIV-1-infected patients. Patients and methods: A retrospective, longitudinal, multicentre analysis of adult patients enrolled in the Antiretroviral Resistance Cohort Analysis (ARCA), a national prospective observational cohort of HIV-1-infected patients followed up at more than 100 clinical and laboratory units in Italy. Patients eligible were those starting first-line antiretroviral therapy between 1 June 2004 and 15 April 2011 and who were followed up for at least 6 months. The primary endpoint was durability, define…

CyclopropanesTime FactorsPyridinesPyridineDrug ResistanceLopinavir/ritonavirLongitudinal StudieHIV InfectionsPharmacologyAntiviral therapyDeoxycytidineLopinavirCohort Studieschemistry.chemical_compoundimmune system diseasesRetrospective StudieOrganophosphonateMedicineEmtricitabineHIV InfectionPharmacology (medical)ViralLongitudinal StudiesProspective StudiesProspective cohort studyvirus diseasesLopinavirInfectious DiseasesAnti-Retroviral AgentsItalyAlkynesCombinationOligopeptideHIV/AIDSDrug Therapy CombinationOligopeptidesmedicine.drugHumanMicrobiology (medical)Benzoxazinemedicine.medical_specialtyEfavirenzTime Factorantiretroviral therapyAtazanavir SulfateOrganophosphonatesfirst-line therapy tenofovir emtricitabine atazanavir/ritonavirSettore MED/17 - MALATTIE INFETTIVEEmtricitabineDurabilityDrug TherapyInternal medicineDrug Resistance ViralDrug utilizationHumansAntiviral therapy; Drug utilization; Durability; HIV/AIDS; Tenofovir/emtricitabine; Adenine; Anti-Retroviral Agents; Benzoxazines; Cohort Studies; Deoxycytidine; Drug Resistance Viral; Drug Therapy Combination; HIV Infections; HIV-1; Humans; Italy; Longitudinal Studies; Lopinavir; Oligopeptides; Organophosphonates; Prospective Studies; Pyridines; Retrospective Studies; Ritonavir; Time Factors; Pharmacology; Pharmacology (medical); Infectious DiseasesTenofovirRetrospective StudiesAntiviral therapy; Drug utilization; Durability; HIV/AIDS; Tenofovir/emtricitabine; Adenine; Anti-Retroviral Agents; Atazanavir Sulfate; Benzoxazines; Cohort Studies; Deoxycytidine; Drug Resistance Viral; Drug Therapy Combination; Emtricitabine; HIV Infections; HIV-1; Humans; Italy; Longitudinal Studies; Lopinavir; Oligopeptides; Organophosphonates; Prospective Studies; Pyridines; Retrospective Studies; Ritonavir; Tenofovir; Time FactorsPharmacologyRitonavirbusiness.industryAdenineAtazanavirBenzoxazinesRegimenProspective StudiechemistryHIV-1RitonavirAnti-Retroviral AgentCohort StudieTenofovir/emtricitabinebusiness
researchProduct

"Eeny, Meeny, Miny, Moe": Prioritizing Medications on the Prescription as an Unexplored Avenue Towards Optimizing Geriatric Pharmacotherapy.

2018

Drug UtilizationMalemedicine.medical_specialtyMEDLINEDrug PrescriptionsPharmacotherapyDrug TherapyMedicineHumansMedical prescriptionIntensive care medicineGeriatric AssessmentGeneral NursingAgedPolypharmacyAged 80 and overbusiness.industryHealth PrioritiesHealth PolicyGeneral MedicineDrug UtilizationPolypharmacyFemaleFranceGeriatrics and GerontologybusinessJournal of the American Medical Directors Association
researchProduct

A prospective study of adverse drug reactions as a cause of admission to a paediatric hospital

1996

1A total of 512 consecutive paediatric hospital admissions of children 2 years old or less were evaluated to assess the extent and pattern of admission caused by suspected adverse drug reactions (ADRs). The proportion of suspected ADRs related to hospital admissions was 4.3%. 2The organ-systems most commonly implicated were the central nervous system (40.5%), digestive system (16.7%), and skin and appendages (14.3%). Together, they accounted for 71.5% of admissions attributed to ADRs. The most common clinical manifestations inducing admission were convulsions (4 cases), dizziness (4), vomiting (3), and tremor, fever, itching and apnoea (2 cases each). 3The four classes of drugs most frequen…

Drug UtilizationMalemedicine.medical_specialtyPediatricsDrug-Related Side Effects and Adverse ReactionsEpidemiologyPharmacovigilanceMedicineHumansPharmacology (medical)Prospective StudiesProspective cohort studyPharmacologybusiness.industryGuaiphenesinInfant NewbornInfantOdds ratioOriginal ArticlesHospitalizationChild PreschoolVomitingItchingFemalemedicine.symptombusiness
researchProduct

Why are our patients still suffering pain?

2007

Legal barriers, restricted resources, lack of physician training, and physician and patient worries about potential opioid addiction can be barriers to effective and rational pain management in patients with cancer pain. Sebastiano Mercadante discusses these issues, as well as suggesting interventions for improving care.

Drug UtilizationNarcoticsmedicine.medical_specialtyCulturePsychological interventionMEDLINEPainNeoplasmsPhysiciansmedicineHumansPain ManagementIn patientIntensive care medicineOpioid addictionPain MeasurementAnalgesicsEducation Medicalbusiness.industryfood and beveragesGeneral MedicinePain managementDrug UtilizationOncologyAttitudeCaregiversDrug and Narcotic ControlbusinessCancer painNature clinical practice. Oncology
researchProduct